Skip to Main Content

Paper Details

Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Acta Neuropathol
2
2023
MB, Medulloblastoma, RNA, SGS, SGS MB, SHH, SHH MB, WNT, WNT/, malignant pediatric brain tumor, medulloblastoma, metagene sets, non-, non-SHH MB, non-WNT/non-SHH MB, non-WNT/non-SHH medulloblastoma subgroups, patients, survival, survival-associated genes, transcriptome, tumor, tumors
Author NameAffiliation
Andrey KorshunovClinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ)
Andrey KorshunovHeidelberg University Hospital
Andrey KorshunovClinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Andrey KorshunovHeidelberg University Hospital
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ)
Konstantin OkonechnikovHopp Children's Cancer Center Heidelberg (KiTZ)
Konstantin OkonechnikovGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Jan KosterCenter for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam and Cancer Center Amsterdam
Jan KosterCenter for Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam and Cancer Center Amsterdam
Till MildeClinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Till MildeHeidelberg University Hospital
Felix SahmClinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Felix SahmHopp Children's Cancer Center Heidelberg (KiTZ)
Felix SahmHeidelberg University Hospital
Felix SahmClinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Felix SahmHeidelberg University Hospital
Felix SahmHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Andreas von DeimlingClinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Andreas von DeimlingHopp Children's Cancer Center Heidelberg (KiTZ)
Andreas von DeimlingHeidelberg University Hospital
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHeidelberg University Hospital
Marcel KoolHopp Children's Cancer Center Heidelberg (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolHopp Children's Cancer Center Heidelberg (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
  • 1 - 39

Datasets